Genmab Stock Soars After Upgraded Revenue Forecast

Biotech company Genmab's shares surged on the stock market after it raised its annual revenue forecast, citing stronger-than-expected sales of several cancer medications.

Post Share

Sources

Showing 0 of 1 sources

No articles available in your preferred languages.

1 article available in other languages below.

berlingskeDanish24d ago

Genmab stryger til vejrs på børsen efter opjustering

Biotekselskabet Genmab venter en højere omsætning i år, da salget af flere kræftmidler går bedre end ventet.

Read full article →

Genmab Stock Soars After Upgraded Revenue Forecast

Sources

Genmab stryger til vejrs på børsen efter opjustering

Related Stories

Anthropic Secures $35 Billion Cloud Computing Agreement With Lambda

Apple CEO Tim Cook Steps Down, Sends Farewell Memo to Employees

Hyundai Motor Workers Approve New Wage Agreement

OPay Denies Viral Rumors of Imminent Service Shutdown in Nigeria